Clicks GroupCCKRF 70 EBITDA Margin % is 13.27% as of Feb. 2026, which is 13% above its 10-year median of 11.73. GuruFocus rates CCKRF with a GF Score™ of 70/100 and a GF Value™ of $23.61 (Significantly Undervalued). Among 668 Healthcare Providers & Services companies, Clicks Group ranks better than 59.28% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Clicks Group's EBITDA for the
six
months ended in Feb. 2026 was $206 Mil. Clicks Group's Revenue for the
six
months ended in Feb. 2026 was $1,555 Mil. Therefore, Clicks Group's EBITDA margin for the quarter that ended in Feb. 2026 was 13.27%.
Clicks Group (OTCPK:CCKRF) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Clicks Group EBITDA Margin % Related Terms
Clicks Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Clicks Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group EBITDA Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Clicks Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Clicks Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group (CCKRF) has a EBITDA Margin % of 13.27% as of Feb. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clicks Group and its competitors. This is 13% above median its historical median of 11.73. Over the past decade, Clicks Group's EBITDA Margin % has ranged from 7.60 to 14.00. According to the industry distribution chart, Clicks Group ranks #272 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 40.7%.
Is Clicks Group's EBITDA Margin % too high?
Clicks Group's current EBITDA Margin % of 13.27% is 13% above median its 10-year median of 11.73. Over the past 10 years, this metric has ranged from a low of 7.60 to a high of 14.00. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Clicks Group's value of 13.27% is 30% above this industry median. Based on the distribution chart, Clicks Group ranks #272 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clicks Group has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's EBITDA Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #272 out of 668 companies for EBITDA Margin %. This puts Clicks Group in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Clicks Group's value of 13.27% is 30% above this benchmark. Historically, Clicks Group's own EBITDA Margin % has ranged from 7.60 to 14.00 over the past decade. While the company's 10-year median is 11.73 vs. the industry median of 10.21, Clicks Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clicks Group's current EBITDA Margin % of 13.27% is 30% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Clicks Group and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clicks Group's current EBITDA Margin % is 13.27%, which is 13% above median its own 10-year median of 11.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CCKRF) is currently considered Significantly Undervalued. The stock's GF Value™ is $23.61, compared to a current price of $15.65 — trading 33.7% below its estimated fair value. The current EBITDA Margin % is 13.27%, which is 13% above median its 10-year median of 11.73 and 30% above the Healthcare Providers & Services industry median of 10.21. Clicks Group's overall GF Score™ is 70/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Clicks Group (CCKRF), the current EBITDA Margin % is 13.27% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CCKRF) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $15.65 is trading 33.7% below its estimated GF Value™ of $23.61.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CCKRF:
EBITDA Margin %: 13.27% (13% above median its 10-year median of 11.73)
GF Value™: $23.61 vs. price of $15.65 (33.7% below fair value)
Industry Position: 30% above the Healthcare Providers & Services median (#272 of 668)
No single metric tells the full story. See the CCKRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
70GF Score
Get the complete analysis for CCKRF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCKRF has been successfully added to your 
